Demographics and outcomes of patients younger than 75 years undergoing aortic valve interventions in Rotterdam
At the Erasmus University Medical Centre, in patients < 75 years, TAVI is selected for higher-risk phenotypes and overall has higher long-term mortality than SAVR. We found no evidence for worse outcome within risk categories.
Authors
- Nicolas M. Van Mieghem (ORCID: https://orcid.org/0000-0002-2732-1205)
- Rik Adrichem (ORCID: https://orcid.org/0000-0002-1001-8840)
- Mattie Lenzen (ORCID: https://orcid.org/0000-0002-2292-3258)
- Joost Daemen (ORCID: https://orcid.org/0000-0001-8628-1410)
- Mark M P van den Dorpel (ORCID: https://orcid.org/0009-0003-2124-109X)
- Isabella Kardys (ORCID: https://orcid.org/0000-0002-2115-9745)
- Paul Cummins (ORCID: https://orcid.org/0000-0003-2902-704X)
- Thijmen W. Hokken
- Jos A. Bekkers (ORCID: https://orcid.org/0000-0002-0221-9239)
- Antonio Maarten Mattace-Raso
- Marjo J. A. G. de Ronde
- Rutger‐Jan Nuis
Institutions
- Erasmus MC (NL)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- Netherlands Heart Journal
- Published
- 2024-08-20
- DOI
- https://doi.org/10.1007/s12471-024-01888-2
- Citations
- 4
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.61